---
title: "Chongqing Xishan Science&Technology Co.,ltd. (688576.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688576.SH.md"
symbol: "688576.SH"
name: "Chongqing Xishan Science&Technology Co.,ltd."
industry: "Health Care Equipment"
---

# Chongqing Xishan Science&Technology Co.,ltd. (688576.SH)

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Location | CN Market |
| Website | [www.xishantech.com.cn](https://www.xishantech.com.cn) |

## Company Profile

Chongqing Xishan Science & Technology Co., Ltd. engages in the research and development, manufacturing, sale, and service of digital minimally invasive surgical equipment and medical consumables in China and internationally. The company offers powered surgical instruments, such as micromotor, handpi...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:11.000Z

**Overall: C (0.46)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 49 / 63 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.59% |  |
| Net Profit YoY | -35.67% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.11 |  |
| Dividend Ratio | 1.25% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.63B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 359.84M |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.34% | C |
| Profit Margin | 21.17% | A |
| Gross Margin | 63.39% | A |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.59% | C |
| Net Profit YoY | -35.67% | D |
| Total Assets YoY | -2.14% | D |
| Net Assets YoY | -4.21% | D |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 472.44% | C |
| OCF YoY | 1.59% | C |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.19 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 8.11% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Chongqing Xishan Science&Technology Co.,ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.34%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "21.17%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "63.39%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "1.59%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-35.67%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-2.14%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-4.21%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "472.44%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "1.59%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.19",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "8.11%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | United Imaging Healthcare (SH.688271) | B | B | C | B | B | B |
| 02 | YUYUE MEDICAL (SZ.002223) | B | B | C | A | C | B |
| 03 | APT (SH.688617) | A | B | B | A | B | B |
| 04 | iRay (SH.688301) | A | B | E | A | B | B |
| 05 | ZHENDE MEDICAL (SH.603301) | C | B | C | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 47.65 | 27/66 | 40.61 | 37.51 | 33.94 |
| PB | 2.11 | 13/66 | 2.09 | 1.78 | 1.69 |
| PS (TTM) | 10.09 | 45/66 | 9.50 | 8.85 | 8.54 |
| Dividend Yield | 1.24% | 22/66 | 1.70% | 1.56% | 1.46% |

## Institutional View

### Analyst Rating Distribution

> As of 2025-03-23T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 1 | 100% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 79.76 |

## References

- [Company Overview](https://longbridge.com/en/quote/688576.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688576.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688576.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.